|
1.
Share Success: Letters From Readers
Letter I: From Marilyn G.
Received
at Customer Service (customerservice @ ezorbonline.com) Thursday, December 19, 2019, 7:05 AM PST
(Unedited)
Last night we ordered again for my husband. I think it came across as another order for me.
I wanted to tell you that I'm beginning to see some changes in my body.
My second bottle should arrive today . I first noticed that when the jar of mayo fell from the fridge, hitting my big toe, the pain did not last very long at all.
Then yesterday after sitting in a chair at the bank, for an hour I stood up and walked almost like a normal person. Yes!
I am 76. Thanks for this product.
Letter II: From Rebecca, Midwest
Received
at Testimonial Submit Form Tuesday, December 17, 2019 at 07:30:45
(Unedited)
Rebecca: Midwest region.
I am in the medical field and had tried different calcium brands but none worked.
I have been taking EZorb for 3 months now and can tell a huge difference in my joints and nails.
My nails don't break anymore. I am very active with multiple workouts (including hiking) and my joints don't hurt anymore.
This is the first calcium supplement I can honestly say works and does not upset my stomach. I will continue to take it!
***************************************************
From
the Desk of EZorb Newsletter Editor:
This
newsletter is now read by over 120,000 subscribers
worldwide. Success stories you have contributed over
the years have had a great impact on many people's
quality of life. Your continuous support will be
greatly appreciated by tens of thousands who have been
suffering and would continuously suffer, without your
help! Please email your
story to sharesuccess @ ezorbonline.com
or simply post it at Testimonial
Submit Form. Your personal information will never be
revealed to the public. We appreciate your effort.
2.
Research News: Hydroxychloroquine May Work for COVID-19
Preliminary findings from a small open-label study suggest that repurposing hydroxychloroquine - an antimalarial agent and DMARD - may be a feasible strategy for COVID-19 that merits further investigation.
Among 20 hospitalized patients aged an average of 45.1 years with confirmed severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) infection who were treated with oral hydroxychloroquine sulfate 200 mg thrice daily for 10 days, 70.0% achieved virologic clearance in nasopharyngeal samples at the 6-day follow-up.
By comparison, virologic clearance was reported in 12.5% of 16 control patients who did not receive hydroxychloroquine because they did not meet inclusion criteria, refused study treatment, or were treated at another center.
Didier Raoult (IHU-Mediterranean Infection, Marseille, France) and team note that six participants received the antibiotic azithromycin (500 mg on day 1, then 250 mg/day for 4 days) in addition to hydroxychloroquine "to prevent bacterial super-infection," and rates of viral clearance in these patients "suggest a synergistic effect of the combination." All six patients receiving both treatments achieved virologic clearance at day 6, compared with 57.1% of the 14 treated with hydroxychloroquine alone.
While the investigators believe that their findings "should be shared with the scientific community" in light of "the urgent need for an effective drug against SARS-CoV-2," they caution that their preliminary investigation has a number of limitations, including small patient numbers and limited duration of follow-up.
"Further works are also warranted to determine if these compounds could be useful as chemoprophylaxis to prevent the transmission of the virus, especially for healthcare workers," they write in the International Journal of Antimicrobial Agents.
The ACR has issued a statement acknowledging that the US FDA has been asked to fast-track potential treatments for COVID-19, including chloroquine and hydroxychloroquine, for evaluation.
"Rheumatologists have extensive experience using these drugs and understand their safety and efficacy, including for our patients with rheumatic disease who take these medications on a regular basis," says the ACR, and calls for "pragmatic clinical trials of these drugs [that] can be done quickly to determine how well they work, who should get them, and at what point in the illness."
Original article was published in Int J Antimicrob Agents 2020; doi:10.1016/j.ijantimicag.2020.105949.
3.
Useful Links
Frequently
Asked Questions & Answers
EZorb
Clinical Studies
Marvlix
Benefits
Order
Now
4.
Calcium
Absorption Test
EZorb
Calcium has set a new world record of absorption rate.
You can compare EZorb with other calcium supplements
by using the simple step-by-step instructions we
provide. E-mail your request to test @ elixirindustry.com
for a copy of the instructions.
5.
What Are Others Saying About EZorb and Marvlix?
EZorb and Marvlix have restored confidence in thousands of men
and women. It has brought happiness and healthy life
to families around the world. Click here
to read what people say about EZorb and Marvlix. |
